ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MORRIS LAINER MD

2 HOSPITAL DRIVE SUITE 101 HOLYOKE ASSOCIATES IN INTERNAL MEDICINE

Holyoke | Massachusetts | 01040

(413) 536-6902

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,947Medicare Part D Prescriptions Filled, Including Refills

Rank: 182 out of 2456

$415K Total Retail Price of All Prescriptions

Rank: 327 out of 2456

556 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

5% of this provider’s 6,743 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 629 494 1 1
HYDROCHLOROTHIAZIDE 431 379 2 7
OMEPRAZOLE 402 262 3 3
SIMVASTATIN 374 241 4 2
LOVASTATIN 358 273 5 34
ATENOLOL 352 324 6 6
AMLODIPINE BESYLATE 305 262 7 5
METOPROLOL TARTRATE 277 181 8 10
GLYBURIDE 276 252 R 9 40
METFORMIN HCL 246 177 10 11
LEVOTHYROXINE SODIUM 240 154 11 4
FUROSEMIDE 213 140 12 8
ZOLPIDEM TARTRATE 211 113 13 28
OXYCODONE HCL 188 56 S2 14 38
PROAIR HFA 187 106 15 22
HYDROCODONE-ACETAMINOPHEN 186 93 S3 16 20
ATORVASTATIN CALCIUM 128 101 17 12
OXYCODONE-ACETAMINOPHEN 117 82 S2 18 35
ALLOPURINOL 111 93 19 27
ADVAIR DISKUS 108 50 20 36
PANTOPRAZOLE SODIUM 103 94 21 37
FLUTICASONE PROPIONATE 89 53 22 30
AZITHROMYCIN 88 62 23 60
WARFARIN SODIUM 84 82 24 9
FLUOXETINE HCL 82 27 25 45
OXYCODONE HCL-ACETAMINOPHEN 81 14 S2 26 101
CEPHALEXIN 76 50 27 153
INSULIN SYRINGE 76 41 27 72
TAMSULOSIN HCL 73 61 29 32
TRIAMTERENE-HCTZ 70 70 30 53
LORAZEPAM 69 69 31 67
CARISOPRODOL 68 39 R 32 179
SERTRALINE HCL 67 60 33 21
CITALOPRAM HBR 66 31 34 14
GABAPENTIN 64 43 35 16
CYCLOBENZAPRINE HCL 61 19 R 36 77
TRAMADOL HCL 60 21 37 24
IBUPROFEN 59 30 38 52
LANTUS 55 40 39 44
PREDNISONE 53 38 40 39
CIPROFLOXACIN HCL 50 32 41 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.